Results 81 to 90 of about 919 (150)
Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis.
BACKGROUND: Bacterial vaginosis (BV) and Trichomonas vaginalis (TV) have been estimated to affect one-quarter to one-third of sexually active women worldwide, and are often found concurrently. Few studies have examined this relationship longitudinally to
Madhivanan, Purnima +11 more
core +1 more source
BACKGROUND: Audio computer-assisted self-interviews (ACASI) are increasingly used in health research to improve the accuracy of data on sensitive behaviors.
Minnis, Alexandra M +7 more
core +1 more source
Predisposing factors of recurrent vulvovaginal candidiasis III.
1 ABSTRACT In this study we are dealing with problems of recurrent vulvovaginal candidiasis. Vulvovaginal candidiasis is one of the most frequent genital infections. It is hypothesized that 75% of woman experience during their reproductive age at least 1
Hájková, Lucie
core +1 more source
Use of Yeast Lysate in Women with Recurrent Vulvovaginal Candidiasis
Vulvovaginal candidiasis (VVC) affects a significant number of women, especially in working age. In an estimated 75% of women an episode of acute vulvovaginal candidiasis occurs during lifetime and another 5–10% of women develop recurrent vulvovaginal ...
Bittner, L., Nepereny, J., Vrzal, V.
core +1 more source
Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. [PDF]
BACKGROUND: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at ...
Patricia A Buffler +3 more
core +1 more source
Chronic Vulvovaginal Hypersensitivity: An Underrecognized and Undertreated Disorder by Allergists
Vulvovaginal candidiasis infections are estimated to occur at least once during the lifetime of 75% of the female population. It has been proposed that some women with recurrent vulvovaginal candidiasis (RVVC) develop sensitization to Candida albicans ...
Jonathan A. Bernstein M.D. +1 more
doaj +1 more source
Recurrent vulvovaginal Candidiasis and plasma Zinc levels
History and Objectives: Due to prevalence of recurrent vulvovaginal candidiasis effectiveness of fungicide prophylaxis and low levels of Zinc in our population, the present study is conducted in order to find out the relationship between the plasma Zinc ...
Valai, Naser +2 more
core
Designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment [PDF]
CITATION: Woodburn, K. W., et al. 2019. Designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment. Antimicrobial Agents and Chemotherapy, 63(11):e02690-18, doi:10.1128/AAC.02690-18.The original publication is available at https ...
Clemens, L. Edward +6 more
core +1 more source
Recurrent vulvovaginal candidiasis associated with the use of a probiotic supplement
Background: Recurrent vulvovaginal candidiasis (RVVC) is a common cause of morbidity in women with vulvovaginal complaints. Saccharomyces species have been shown to cause vulvovaginal candidiasis in only 2 % - 6 % of RVVC cases. However, these infections
Chemen M. Neal +4 more
doaj +1 more source
Aims. The present study aimed to test the in vitro activity against Candida albicans and non-albicans strains of 18-β glycyrrhetinic acid (18-β GA) and hyaluronic acid (HA), both alone and in combination.
Martina Stevan +6 more
doaj +1 more source

